PPARα Agonist Fenofibrate Reduced the Secreting Load of β-Cells in Hypertriglyceridemia Patients with Normal Glucose Tolerance

Hypertriglyceridemia is an important risk factor associated with insulin resistance and β-cell dysfunction. This study investigated the effects of hypertriglyceridemia and fenofibrate treatment on insulin sensitivity and β-cell function in subjects with normal glucose tolerance. A total of 1974 subj...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PPAR Res
Hlavní autoři: Liu, Jia, Lu, Rui, Wang, Ying, Hu, Yanjin, Jia, Yumei, Yang, Ning, Fu, Jing, Wang, Guang
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2016
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4789521/
https://ncbi.nlm.nih.gov/pubmed/27034649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6232036
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky